Most Popular Stories
Share This Page
Is Goldman Sachs’ 2025 Outlook Correct?
Steve Reitmeister compares his 2025 market outlook to the one just released by Goldman Sachs. There are points of agreement, but biggest disagreement is about where the S&P 500 (SPY) will be at the end of next year. Read on for more...
3 Streaming Stocks Benefiting from Cord-Cutting Trends
As streaming continues to dominate the digital entertainment landscape, the global streaming market presents a lucrative investment opportunity. So, it could be ideal to invest in fundamentally solid streaming stocks Netflix (NFLX), Walt Disney (DIS), and Roku (ROKU). Read further...
3 Gold Stocks to Buy as Safe-Haven Demand Grows
Gold is a stable investment now due to its role as a safe-haven asset during economic uncertainty, rising demand, industrial use, and growth, bolstered by central bank purchases and interest rate cuts. Therefore, investors should consider investing in top gold stocks such as Newmont (NEM), Barrick Gold (GOLD), and Agnico Eagle Mines (AEM). Read more...
3 AI Stocks Transforming Industries and Driving Future Growth
With rapid digitalization, rapid adoption, and development, as well as surging demand, the AI market is on the rise. Amid this backdrop, investors could buy fundamentally solid AI stocks NVIDIA Corporation (NVDA), Microsoft (MSFT), and Meta Platforms (META) poised for substantial gains. Continue reading...
How Much Resistance @ 6,000 for Stocks?
The post-election rally was an exciting burst for the stock market. With that the S&P 500 (SPY) made new highs just above 6,000. Since then stocks have struggled begging the question: what happens next? 44 year investing veteran Steve Reitmeister provides the answers along with his top 11 stocks to buy now.Top Stories
3 Buy-Rated Financial Stocks Locking in Profits
U.S. banks look likely to face pressure from elevated deposit costs, prolonged high interest rates, deteriorating asset quality, and stringent lending standards. Therefore, it could be wise to look beyond borders and buy fundamentally strong financial stocks Woori Financial Group (WF), Erste Group Bank (EBKDY), and Banco Santander (SAN). These stocks are Buy-rated in our proprietary ratings system. Read on...
3 Beverage Stocks Lighting up Wall Street
Despite high input costs and elevated inflation, the beverage industry is expected to perform well due to resilient consumer spending, diverse offerings, and evolving customer preferences. Therefore, investors could consider buying fundamentally strong beverage stocks such as Carlsberg (CABGY), Ambev (ABEV), and Coca-Cola FEMSA (KOF). Read on...
Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?
Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out...
Apple (AAPL) Quarterly Earnings Update: Buy or Wait?
Tech giant Apple (AAPL) has released its first-quarter earnings, revealing record-high services revenue. However, concerns arise from shortcomings in its wearables segments and delayed entry into the generative AI space. Let's analyze AAPL's recent performance, assess key fundamentals, and decide whether to buy or wait on the stock...
3 Biotech Stocks to Consider Buying Right Away
The biotechnology industry is thriving, fueled by solid government support, rising healthcare spending worldwide, gene editing breakthroughs, and rapid AI adoption. Hence, fundamentally solid biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and SIGA Technologies (SIGA) could be ideal buys for potential gains. Keep reading…
Strategies for Capitalizing on Advanced Micro Devices (AMD) Earnings Momentum
Despite an impressive first quarter earnings report, shares of Advanced Micro Devices (AMD) are in a downward spiral. Let's delve into the intricacies of AMD's current market dynamics to uncover the underlying reasons behind this unexpected turn of events...
3 Internet Stocks to Monitor Closely
The internet industry's long-term prospects appear bright thanks to digitalization, increased infrastructure investment, and technological advancements such as 5G networks and the Internet of Things. Given the industry’s solid growth prospects, investors could consider adding fundamentally strong internet stocks, ATRenew (RERE), 1stdibs.Com (DIBS), and Despegar.com (DESP), to their watchlist. Read more...
3 Stocks Poised for Success in the Gold Sector
The gold market is primed for solid growth this year, owing to its appeal as a safe haven, growing demand for gold ornaments, and consistent purchases by central banks worldwide. Given this backdrop, investors could consider buying quality gold stocks: Kinross Gold Corporation (KGC), Centamin (CELTF), and Centerra Gold (CGAU). Read on...
3 Pharma Stocks to Snatch up During Market Dips
The pharmaceutical industry is undergoing rapid growth and expansion, driven by rising medical needs, favorable regulatory measures, and the implementation of pharma 4.0. Hence, investors could snatch up quality pharma stocks Bristol-Myers Squibb (BMY), Spero Therapeutics (SPRO), and OptiNose (OPTN) for steady returns during market dips. Read more...
Top Software Stock May Watchlists
Given the software industry’s remarkable growth trajectory, one might want to add fundamentally top software stocks GoDaddy (GDDY), SS&C Technologies (SSNC), The Sage Group (SGPYY), Yalla Group (YALA), Vimeo (VMEO) to their watchlist this month. So, let’s delve deeper into the fundamentals of these stocks to gauge their potential…
3 Buy-Rated Energy Stocks to Buy in May
Limited oil supply aggravated by geopolitical tensions and solid energy consumption could push oil prices higher, creating significant tailwinds for the energy sector. Thus, energy stocks Energy Transfer (ET), Koninklijke Vopak (VOPKY), and Forum Energy (FET) could be ideal buys in May. These stocks are rated B (Buy) in our proprietary rating system. Read on...
Investors Beware of These 3 Pharma Stocks
Rising costs, regulatory hurdles, and cyberattacks are some of the challenges that the pharmaceutical industry faces. Although the sector looks well-positioned for growth, not all pharma stocks would be able to capitalize on the industry trends. Therefore, investors should look to avoid fundamentally weak pharma stocks: Madrigal Pharmaceuticals (MDGL), Viking Therapeutics (VKTX), and Axsome Therapeutics. (AXSM), given their weak growth prospects. Read on...
3 Chip Stocks Trading at Attractive Prices
The chip industry's long-term growth prospects look promising due to the increasing demand for chips and their ever-expanding applications. Hence, investors could consider buying fundamentally strong chip stocks: Trio-Tech International (TRT), United Microelectronics (UMC), and Everspin Technologies (MRAM), currently trading under $10. Read on...
4 Energy Stocks With Buy Ratings Worth Your Attention
The energy sector is positioned for substantial growth because of increasing global energy demands, geopolitical tensions, and recovering global economies. Therefore, investors could consider buying fundamentally strong energy stocks: Baker Hughes (BKR), Plains All American Pipeline (PAA), Euronav (EURN), and MRC Global (MRC), all of which are Buy-rated in our proprietary rating system. Read on...
Top 4 Internet Stocks for Bullish Investors
The Internet industry appears to be in a bright spot for future growth, thanks to the increasing usage of the Internet globally, advancements in technology, and rising demand for personalized digital platforms and services. Therefore, quality internet stocks such as Jamf Holding Corp. (JAMF), Expedia Group (EXPE), Fiverr International (FVRR), and trivago N.V. (TRVG) could be solid buys for bullish investors now. Read on...
Buy Alert: 3 Pharma Stocks Under $20 to Invest in Now
With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be ideal investments now. Keep reading...
3 A-Rated Pharma Stocks to Buy for Long-Term Growth
With surging medical needs, advances in precision medicine, and the adoption of generative AI, the pharmaceutical industry is thriving. Thus, it could be ideal to invest in quality pharma stocks Taro Pharmaceutical (TARO), AstraZeneca (AZN), and Merck (MRK) for long-term growth. These stocks are rated A (Strong Buy) in our proprietary rating system. Read more...
Biotech Buyers Beware: 3 Stocks to Avoid
The biotech industry is flourishing due to groundbreaking developments in cell and gene therapies and the rapid adoption of new technologies. However, not all biotech stocks are positioned to capitalize on the industry tailwinds. Thus, investors must beware of fundamentally weak stocks: Alpine Immune (ALPN), Kura Oncology (KURA), and Blueprint Medicines (BPMC). Read on…
Will McDonald's (MCD) or Starbucks (SBUX) Be the Better Earnings Momentum Buy?
Technological advancements, rising consumer spending, and eating-out trends boost the restaurant industry’s growth prospects. Restaurant stocks McDonald’s (MCD) and Starbucks (SBUX) announced their earnings recently. Let’s analyze the fundamentals of MCD and SBUX to determine a better earnings momentum buy. Keep reading...